Long-term prognosis after intracerebral haemorrhage.

Koen M van NieuwenhuizenIlonca VaartjesJamie I VerhoevenGabriel Je RinkelL Jaap KappelleFloris Hbm SchreuderCatharina Jm Klijn

Published in: European stroke journal (2020)

The high risk of recurrent ICH, other vascular events and prolonged reduced survival-rates warrant clinical trials to determine optimal secondary prevention treatment after ICH.

Keyphrases

clinical trial
combination therapy
open label
replacement therapy
smoking cessation